Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 4
1974 1
1975 1
1976 1
1977 1
1978 1
1999 5
2000 2
2001 6
2002 4
2003 1
2004 2
2005 1
2006 3
2007 1
2008 1
2009 4
2010 3
2011 3
2012 8
2013 7
2014 7
2015 4
2016 4
2017 14
2018 11
2019 11
2020 16
2021 21
2022 10
2023 9
2024 13
2025 16
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

169 results

Results by year

Filters applied: . Clear all
Page 1
Protocol for a mixed-methods modified Delphi study for the development of a core domain set to assess the health-related quality of life of patients with mycosis fungoides and Sézary syndrome in clinical trials.
Asare C, Raymundo C, Chen J, Perez-Chada L, Tawa M, Thornton S, Ottevanger R, Scarisbrick J, Olsen E, Khan N, Kim EJ, Shinohara MM, Larocca C; International Dermatology Outcomes Measures Cutaneous Lymphoma Working Group Additional Members: Neha Mehta Shah, Jenny Park, Krithika Nayudu. Asare C, et al. Among authors: scarisbrick j. BMJ Open. 2026 Feb 6;16(2):e103498. doi: 10.1136/bmjopen-2025-103498. BMJ Open. 2026. PMID: 41651511 Free PMC article.
Resminostat for maintenance treatment in patients with advanced-stage mycosis fungoides or Sézary syndrome: a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial.
Stadler R, Quaglino P, Woei-A-Jin FJSH, Dummer R, Mitteldorf C, Papadavid E, Ortiz Romero PL, Guenova E, Abe R, Cowan R, Bagot M, Dalle S, Fujimura T, Gambichler T, Morris S, Wehkamp U, Terheyden P, Cozzio A, Dippel E, Alberti-Violetti S, Romejko-Jarosinska J, Wozniacka A, González Barca E, Pujol Vallverdu R, Ramelyte E, Bechter O, Suzuki K, Knobler R, Danhauser-Riedl S, Scarisbrick J; RESMAIN Investigators. Stadler R, et al. Among authors: scarisbrick j. Lancet Haematol. 2026 Feb;13(2):e98-e109. doi: 10.1016/S2352-3026(25)00322-9. Lancet Haematol. 2026. PMID: 41651641 Clinical Trial.
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee.
Damaj G, de Masson A, Dreger P, Bazarbachi A, Berning P, Duarte RF, Fox CP, Guenova E, Hermine O, Kyriakou C, Tanase A, Tournilhac O, Jurczak W, Karsten IE, Quoc SN, Serroukh Y, Stella F, Wulf G, Sureda A, Papadavid E, Ortiz-Romero PL, Ruggeri A, Sánchez-Ortega I, Scarisbrick JJ, Yakoub-Agha I, Onida F, Schmitz N. Damaj G, et al. Among authors: scarisbrick jj. J Eur Acad Dermatol Venereol. 2026 Feb;40(2):174-184. doi: 10.1111/jdv.70042. Epub 2025 Oct 1. J Eur Acad Dermatol Venereol. 2026. PMID: 41031482 Free PMC article. Review.
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee.
Damaj G, de Masson A, Dreger P, Bazarbachi A, Berning P, Duarte RF, Fox CP, Guenova E, Hermine O, Kyriakou C, Tanase A, Tournilhac O, Jurczak W, Karsten IE, Quoc SN, Serroukh Y, Stella F, Wulf G, Sureda A, Papadavid E, Ortiz-Romero PL, Ruggeri A, Sánchez-Ortega I, Scarisbrick JJ, Yakoub-Agha I, Onida F, Schmitz N. Damaj G, et al. Among authors: scarisbrick jj. Bone Marrow Transplant. 2025 Dec;60(12):1565-1573. doi: 10.1038/s41409-025-02696-x. Epub 2025 Oct 1. Bone Marrow Transplant. 2025. PMID: 41034407 Free PMC article. Review.
European Organisation for Research and Treatment of Cancer, United States Cutaneous Lymphoma Consortium and International Society for Cutaneous Lymphomas consensus recommendations for management and treatment of cutaneous lymphoproliferative disorders.
Willemze R, Assaf C, Bagot M, Beylot-Barry M, Berti E, Busschots AM, Cerroni L, Climent F, Diercks G, Geskin L, Gniadecki R, Gru AA, Guenova E, Guitart J, Jansen P, Kempf W, Kim E, Kim YH, Koldijk M, Marschalkó M, Mitteldorf C, Molgó M, Muniesa C, Neelis KJ, Olsen E, Ortiz-Romero PL, Papadavid E, Pimpinelli N, Pulitzer M, Quaglino P, Querfeld C, Quint K, Scarisbrick JJ, Schrader AMR, Stadler R, Vermeer M, Wehkamp U, Whittaker S, Wobser M. Willemze R, et al. Among authors: scarisbrick jj. Br J Dermatol. 2025 Nov 18;193(6):1090-1100. doi: 10.1093/bjd/ljaf312. Br J Dermatol. 2025. PMID: 40795052
A new prognostic index (CLIPI) for advanced cutaneous lymphoma enables precise patient risk stratification.
Scarisbrick JJ, Quaglino P, Whittaker S, Bagot M, Guenova E, Papadavid E, Prince HM, Sanches JA, Miyashiro DR, Servitje O, Querfeld C, Akilov O, Arumainathan A, Bennett L, Battistella M, Benstead K, Berti E, Beylot-Barry M, Busschots AM, Cowan R, Dummer R, Dunnill G, Estrach T, Evison F, Bashir A, Geskin L, Gru A, Guitart J, Herrera MC, Hodak E, Horwitz S, Jonak C, Klemke CD, Knobler R, Mckay P, Marschalkó M, Massone C, Matin R, Mitteldorf C, Novoa R, Ortiz-Romero P, Pimpinelli N, Pujol RM, Ranki A, Vakeva L, Rieger KE, Stadler R, Trautinger F, Latzka J, Vermeer M, Wachsmuth R, Weatherhead S, Wehkamp U, Wobser M, Kim YH. Scarisbrick JJ, et al. Blood. 2025 Oct 2;146(14):1687-1692. doi: 10.1182/blood.2025029628. Blood. 2025. PMID: 40663780 Clinical Trial.
169 results